Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Empagliflozin in Heart Failure Patients With Reduced Ejection Fraction: A Randomized Clinical Trial (Empire HF)

NCT03198585 is registered in ClinicalTrials.gov with Morten Schou as lead sponsor.

NCT NCT03198585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03198585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Empagliflozin in Heart Failure Patients With Reduced Ejection Fraction: A Randomized Clinical Trial (Empire HF)
Lead sponsor
Morten Schou
Phase
Phase 2
Overall status
Completed
Start date
June 29, 2017
Completion date
January 17, 2020
Enrollment
190 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with reduced ejection fraction